More details on LinkedIn profile
January 2020 – Present Chief Scientific Officer Asia-Pacific, Ferring Pharmaceuticals, Shanghai, China
December 2016 – December 2019 Vice-President, Reproductive Medicine & Women’s Health, Research & Development, Ferring Pharmaceuticals, Copenhagen, Denmark
September 2015 – Present Visiting Professor, Faculty of Applied Sciences, Department of Pharmacy, Health & Wellbeing, University of Sunderland, UK
January 2014 – June 2015 Vice-President, Head Global Medical Directors Group, Global Medical Affairs, Teva Pharmaceuticals, Amsterdam, The Netherlands
March 2013 – December 2013 Vice-President, Global Clinical Development, Women’s Health R&D, Teva Pharmaceuticals, Utrecht/Amsterdam, The Netherlands
April 2012 – June 2013 Chairman, Dutch Clinical Trial Foundation
September 2011 – August 2012 Vice-President, Merck Research Laboratories, Innovation Office, Merck for Mothers, Oss, The Netherlands
November 2010 – June 2016 President of the Dutch Association of Pharmaceutical Medicine
September 2010 – August 2015 Professor of Pharmaceutical Medicine, Radboud University Nijmegen Medical Centre, The Netherlands
November 2009 – September 2011 Vice-President, Clinical Research, Women’s Health & Endocrine and Site Co-ordinator, Clinical Development, Merck Research Laboratories, MSD, Oss, The Netherlands
May 2008 – October 2009 Vice-President, Women’s Health, Global Clinical Research, and Site Head, Global Clinical Development, Schering-Plough Research Institute, Oss, The Netherlands.
April 2007 – April 2008 Senior Vice-President, Clinical Research & Development, Organon International, Oss, The Netherlands
May 2005 – March 2007 Vice-President, Global Clinical Development, Organon International, Oss, The Netherlands
January 2005 – April 2005 Senior Executive Director, Clinical Development Department, Organon International, Oss, The Netherlands.
January 2002 – December 2004 Senior Director Medical Services, Contraception (‘Director Medical Affairs’), Global Marketing, Organon International, Roseland, NJ, USA.
January 1999 – December 2001 Medical Director, Organon Laboratories, Cambridge, United Kingdom
November 1994 – December 1998 International Medical Adviser Profertility, International Marketing Services, Organon International, Oss, The Netherlands
August 1992 – October 1994 Medical Adviser/Medical Research Project Manager Reproductive Medicine Section, Medical Research & Development Unit/Clinical Development Department, Organon International, Oss, The Netherlands
July 1991 – August 1992 Residency Obstetrics/Gynaecology, Department of Obstetrics and Gynaecology, University Hospital Utrecht, The Netherlands.
April 1991 PhD thesis on: “Antiphospholipid antibodies and human reproduction. Studies on the lupus anticoagulant and anticardiolipin antibodies in patients with systemic lupus erythematosus.” State University Utrecht, The Netherlands.
January 1989 – June 1989 Medical coordinator (1/10) for the national Systemic Lupus Erythematosus (SLE) working party, The Netherlands
November 1987 – October 1990 Clinical Research Fellowship (5/10, University Hospital Utrecht, The Netherlands), on efficacy of medical treatment of pregnant women with antiphospholipid antibodies.
April/May and June/July, 2006 International Executive Programme (IEP), INSEAD, Fontainebleau, France
April 1991 Academic promotion to PhD, State University Utrecht, The Netherlands
September 1979 – March 1987 Medical School, Free University, Amsterdam, The Netherlands